PL EN
REVIEW ARTICLE
NEUROPHYSIOLOGICAL MECHANISMS OF TRIGEMINAL NEURALGIA – FROM DEMYELINATION PATHOLOGY TO CENTRAL SENSITIZATION
 
More details
Hide details
1
Medical Student, Medical University of Warsaw, Warsaw, Poland
 
 
Submission date: 2025-11-30
 
 
Final revision date: 2026-01-05
 
 
Acceptance date: 2026-01-05
 
 
Publication date: 2026-03-16
 
 
Corresponding author
Dariusz Adam Andrzejuk   

Medical Student, Medical University of Warsaw, Żwirki i Wigury 61, 02091 Warsaw, Poland
 
 
Issue Rehabil. Orthop. Neurophysiol. Sport Promot. 2025;52(3):35-43
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Trigeminal neuralgia (TN) is a severe neuropathic pain disorder characterized by brief, electric shock – like attacks within the trigeminal distribution. Although classically linked to neurovascular compression, recent evidence indicates that its pathophysiology extends beyond peripheral mechanisms to include central sensitization and neuroinflammatory processes.

Aim:
The aim of this review was to analyze the neurophysiological mechanisms of TN, emphasizing the interplay between demyelination, altered ion channel expression, and central plasticity, as well as to present modern diagnostic and therapeutic approaches targeting these mechanisms.

Materials and Methods:
The study is a narrative review drawing on current evidence-based literature concerning the peripheral and central mechanisms of TN, including electrophysiological, neuroimaging, and experimental model data.

Results:
Peripheral demyelination at the root entry zone promotes ectopic discharges and ephaptic transmission between adjacent fibers, while upregulation of voltage-gated sodium channels (Nav1.6, Nav1.7) enhances neuronal hyperexcitability. Central sensitization involves activation of microglia and astrocytes releasing proinflammatory cytokines (interleukin-1β, tumor necrosis factor-α, interleukin-6) and neurotrophins (brain-derived neurotrophic factor), contributing to persistent pain. Neuroimaging demonstrates cortical and subcortical reorganization in pain-processing regions. Therapeutic advances include selective sodium and calcium channel blockers and microvascular decompression.

Conclusions:
TN arises from an interplay between peripheral demyelination and central neuroplasticity. Understanding these interconnected mechanisms provides a foundation for more targeted and effective therapeutic strategies that address both neuronal hyperexcitability and neuroinflammation.
REFERENCES (32)
1.
Cruccu G, Finnerup NB, Jensen TS, et al. Trigeminal neuralgia: new classification and diagnos¬tic grading for practice and research. Neurology 2016; 87: 220–228.
 
2.
Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia – diagnosis and treatment. Cephalalgia 2017; 37: 648–657.
 
3.
Obermann M. Recent advances in understanding/ managing trigeminal neuralgia. F1000Res 2019; 8: 505. DOI: 10.12688/f1000research.16092.1.
 
4.
Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001; 124: 2347–2360.
 
5.
Grasso G, Landi A, Alafaci C. A novel pathophysiological mechanism contributing to trigeminal neuralgia. Mol Med 2016; 22: 452–454.
 
6.
Bista P, Imlach WL. Pathological mechanisms and therapeutic targets for trigeminal neuropathic pain. Medicines (Basel) 2019; 6: 91. DOI: 10.3390/medicines6030091.
 
7.
Zakrzewska JM, Linskey ME. Trigeminal neu¬ralgia. BMJ 2015; 350: h1238. DOI: 10.1136/ bmj.h1238.
 
8.
Bochenek A, Reicher M. Anatomia człowieka. Tom IV: Ośrodkowy układ nerwowy. Nerwy czaszkowe i rdzeniowe. Warszawa: Wydawnic¬two Lekarskie PZWL; 2018.
 
9.
Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: an overview from pathophysiology to pharmacological treat¬ments. Mol Pain 2020; 16: 1744806920901890. DOI: 10.1177/1744806920901890.
 
10.
Adam MI, Lin L, Makin AM, et al. Glial cell line– derived neurotrophic factor and brain-derived neurotrophic factor regulate the interaction between astrocytes and Schwann cells at the trigeminal root entry zone. Neural Regen Res 2023; 18: 1364–1370.
 
11.
Zhang X, Li Y, Zhou M, Wei Z. Microvascular decompression in trigeminal neuralgia with the offending artery transfixing the nerve: a case report. BMC Neurol 2022; 22: 244. DOI: 10.1186/s12883-022-02765-4.
 
12.
Thomas KL, Vilensky JA. The anatomy of vascular compression in trigeminal neuralgia. Clin Anat 2014; 27: 89–93.
 
13.
Tanaka BS, Zhao P, Dib-Hajj FB, et al. A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia. Mol Med 2016; 22: 338–348.
 
14.
Chen Q, Yi DI, Perez JNJ, et al. The molecular basis and pathophysiology of trigeminal neural¬gia. Int J Mol Sci 2022; 23: 3604. DOI: 10.3390/ ijms23073604.
 
15.
Liu Y, Tanaka E. Pathogenesis, diagnosis, and management of trigeminal neuralgia: a nar¬rative review. J Clin Med 2025; 14: 528. DOI: 10.3390/jcm14020528.
 
16.
Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT. Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 2009; 164: 573–577.
 
17.
Ostertag C, Friedman TN, Keough MB, Kerr BJ, Sankar T. Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia. Pain Rep 2023; 8: e1117. DOI: 10.1097/PR9.0000000000001117.
 
18.
Liu H, Hou H, Li F, et al. Structural and functional brain changes in patients with classic trigeminal neuralgia: a combination of voxel-based morphometry and resting-state functional MRI study. Front Neurosci 2022; 16: 930765. DOI: 10.3389/fnins.2022.930765.
 
19.
DeSouza DD, Davis KD, Hodaie M. Reversal of insular and microstructural nerve abnormalities following effective surgical treatment for trigeminal neuralgia. Pain 2015; 156: 1112–1123. DOI: 10.1097/j.pain.0000000000000156.
 
20.
Oshida S, Saura H, Akamatsu Y, et al. Delayed blink R1 latency in a patient with trigeminal neuralgia due to a contralateral vestibular schwannoma: an illustrative case. Surg Neurol Int 2023; 14: 284. DOI: 10.25259/SNI_422_2023.
 
21.
Stöhr M, Petruch F, Scheglmann K. Somatosen¬sory evoked potentials following trigeminal nerve stimulation in trigeminal neuralgia. Ann Neurol 1981; 9: 63–66.
 
22.
Zhao YX, Miao SH, Tang YZ, et al. Trigeminal somatosensory-evoked potential: a neurophysiological tool to monitor the extent of lesion of ganglion radiofrequency thermocoagulation in idiopathic trigeminal neuralgia. Medicine (Baltimore) 2017; 96: e5872. DOI: 10.1097/ MD.0000000000005872.
 
23.
Takeda M, Tsuboi Y, Kitagawa J, Nakagawa K, Iwata K, Matsumoto S. Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain. Mol Pain 2011; 7: 5. DOI: 10.1186/1744-8069-7-5.
 
24.
Xu M, Aita M, Chavkin C. Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions. J Pain 2008; 9: 1036–1048. DOI: 10.1016/j.jpain.2008.06.006.
 
25.
Guo R, Fang Y, Zhang Y, et al. SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway. J Nanobiotechnology 2023; 21: 458. DOI: 10.1186/s12951-023-02221-6.
 
26.
Kwon M, Jung IY, Cha M, Lee BH. Inhibition of the Nav1.7 channel in the trigeminal ganglion relieves pulpitis inflammatory pain. Front Pharmacol 2021; 12: 759730. DOI: 10.3389/ fphar.2021.759730.
 
27.
Henssen D, van Dijk J, Knepflé R, Sieffers M, Winter A, Vissers K. Alterations in grey matter density and functional connectivity in trigeminal neuropathic pain and trigeminal neu¬ralgia: a systematic review and meta-analysis. Neuroimage Clin 2019; 24: 102039. DOI: 10.1016/ j.nicl.2019.102039.
 
28.
Xu R, Xie ME, Jackson CM. Trigeminal neuralgia: current approaches and emerging inter¬ventions. J Pain Res 2021; 14: 3437–3463.
 
29.
Cheng JS, Lim DA, Chang EF, Barbaro NM. A review of percutaneous treatments for trigeminal neuralgia. Neurosurgery 2014; 10: 25–33.
 
30.
Rana MH, Khan AAG, Khalid I, et al. Thera-peutic approach for trigeminal neuralgia: a sys¬tematic review. Biomedicines 2023; 11: 2606. DOI: 10.3390/biomedicines11102606.
 
31.
Catalisano G, Campione GM, Spurio G, et al. Neuropathic pain, antidepressant drugs, and inflammation: a narrative review. J Anesth Analg Crit Care 2024; 4: 67.
 
32.
Obata H. Analgesic mechanisms of antidepres¬sants for neuropathic pain. Int J Mol Sci 2017; 18: 2483. DOI: 10.3390/ijms18112483.
 
ISSN:2300-0767
Journals System - logo
Scroll to top